Health

Advocacy Lab Content
03-10-2024

Democracy, demographics, digitalisation at European Health Forum Gastein

Est. 1min

Europe’s health landscape is in constant motion, and the EU’s digital transformation aims to reset this landscape. The European Health Forum Gastein took stock of today’s challenges and the impact of the ‘3Ds’ - democracy, demographics, and digitalisation.

Special ReportAdvocacy Lab Content
26-09-2024

GOALSCORE project, fighting domestic violence through football

Est. 1min

To help tackle violence against women, the EU has launched GOALSCORE, an innovative project aiming to raise awareness and promote football institutional support for gender equality.

Advocacy Lab Content
23-09-2024

GOALSCORE – Global social inclusion: innovative actions against gender differences and prejudice in general

Est. 1min

GOALSCORE - GlObAL Social inclusion: innovative aCtiOns against gender diffeRencEs and prejudice in general

Advocacy Lab Content
19-09-2024

Getting the balance right: AI, digitalisation, and respiratory medicine

Est. 1min

Respiratory diseases are increasingly exacerbated by climate change and worsening air pollution. This special report examines how technology and policy can improve respiratory health.

Advocacy Lab Content
19-09-2024

TARGET – YouTh footbAll players as ambassadoRs for GEnder equaliTy

Est. 1min

The initiative focuses on coach training to promote gender equality within teams, integrating STEM and self-efficacy. A communication campaign will amplify the message across the EU, making TARGET a pioneering effort to address societal gender disparities through the popularity of football.

Advocacy Lab Content
03-09-2024

Antimicrobial resistance fight needs more ambition, new alliances and strategies

Est. 1min

In 2019 alone it’s estimated that AMR was directly responsible for 1.27 million deaths globally. That number could reach 10 million deaths by 2050, mostly in low- and middle-income countries. New alliances, new medicines, and new AMR strategies are needed.

Advocacy Lab Content
24-06-2024

Europe’s personalised medicine sector boosted by Sino-EU PerMed project

Est. 1min

The Sino-EU PerMed project, launched in January 2020, is a bi-regional consortium of six partners from governmental, funding and research organisations to promote personalised medicine cooperation between Europe and China.

Advocacy Lab Content
04-06-2024

Alzheimer’s Disease: detection, diagnosis, treatment

Est. 1min

It is estimated that over 7 million people are living with Alzheimer's Disease in Europe, and there is increasing concern about the ability to combat the disease with Europe's ageing population. In this series of articles, Euractiv will explore the state …

Advocacy Lab Content
27-03-2024

Europe’s human-animal bond, a special report on EU companion animals

Est. 1min

A Human-Animal Bond Report was launched at the EU Companion Animals Stakeholder Summit on 20 March in Brussels, advocating advancements in companion animal policy to improve human and animal health and wellbeing.

Advocacy Lab Content
21-03-2024

Europe’s new Health Technology Assessment Regulation (HTAR) on the horizon

Est. 1min

In early 2025, Europe will implement a uniform, pan-EU framework under the new Health Technology Assessment Regulation (HTAR), addressing disparities in evaluating the clinical value of pharmaceuticals and medical devices.

Advocacy Lab Content
28-02-2024

Europe needs new 360 rare diseases strategy

Est. 1min

Rare Disease Day, 29 February, marks a moment when an estimated 30 million people living with rare diseases across Europe gain a louder voice. Europe now has a generational opportunity to scale up programmes capable of improving millions of lives.

Advocacy Lab Content
14-02-2024

The future of snus in Europe

Est. 1min

The EU executive is currently conducting a comprehensive evaluation of the EU legislative framework on tobacco control, the so-called Tobacco Products Directive (TPD), including via wide public consultations. The existing Directive covers traditional cigarettes and novel products and has imposed severe restrictions.

04-12-2023

Diabetes care in Europe: The path forward

Est. 1min

There are millions of people in Europe who are affected by diabetes and related conditions. This number is only expected to grow in the coming years. However, with technological advancements, it is possible that those affected by the disease are able …

20-11-2023

Navigating challenges: Start-ups in the evolving health-tech landscape

Est. 1min

In the dynamic landscape of the EU's health-tech market, start-ups face a myriad of challenges as they strive to innovate and carve out a niche in an industry characterised by rapid technological advancements and complex regulatory landscapes. In these articles, Euractiv …

Advocacy Lab Content
17-11-2023

The challenges cancer survivors face in Europe

Est. 1min

In cancer care, increasing survivorship comes with its own set of challenges, which include addressing the lasting physical and psycho-social impacts of the disease. In these articles, Euractiv looks at what is needed so that cancer survivors live their lives as …

14-11-2023

Transplantation in the EU: From the waiting lists to post-transplantation journey

Est. 1min

Medical technology innovation and policy advancements are improving the transplantation experience for thousands of people in the European Union.

02-11-2023

Navigating care pathways for stroke survivors across the EU

Est. 1min

As the focus across the EU is usually on the prevention of stroke, post-stroke survivors are often left behind, without no national plans that take into account the need for a continuation of treatment after their discharge from medical institutions.

27-10-2023

The complexity and rewards of gene treatments for rare diseases

Est. 1min

Gene therapies can transform the approach to rare diseases and improve the quality of life for patients. But developing and accessing them is hampered by regulatory burdens, cost and reimbursment schemes. In this special report, Euractiv takes a look at gene …

02-10-2023

Building a resilient EU health union

Est. 1min

The recent years have been generous for EU health policy. COVID-19 pushed forward the creation of the European Health Union and boosted the creation of health policy files. In times of ongoing challenges that healthcare systems across the EU have …

28-09-2023

Antimicrobial resistance: A threat that can no longer be ignored

Est. 2min

During the European Health Forum, representatives of the pharmaceutical industry, EU institutions and patient associations discussed the next steps in fighting the ever-growing threat of antimicrobial resistance (AMR). From accessibility and incentives for research to awareness among the general public, …

26-09-2023

Medicine information leaflets: Paper, digital or both?

Est. 1min

The European Commission's proposed pharmaceutical strategy leaves it to the countries to decide whether the medicine information leaflet is in paper format electronic, or both. However, moving exclusively towards the electronic version could risk leaving behind those lacking digital skills.

26-09-2023

Hampered access to innovative cancer drugs in Spain

Est. 1min

Medical societies, patient associations, and independent experts are pressing for expedited access to innovative cancer treatments in Spain, citing a noticeable lag and lack of alternatives in the process. Spain faces a "structural problem" when assessing and funding innovative cancer drugs. …

15-09-2023

How worsening air quality affects the wellbeing of respiratory disease patients

Est. 1min

Climate change is exacerbating threats to human health, especially affecting the health and well-being of those suffering from respiratory diseases.  Air pollution is one of the biggest environmental threats to human health, causing at least 238,000 premature deaths per year, according …

21-06-2023

The threat of anaphylaxis in Europe, unmasked

Est. 1min

How to prevent anaphylaxis and inequalities caused by divergent access to first-line emergency treatments across Europe?